Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Drug Discovery Today|November 28, 2018
Phosphinic acids: current status and potential for drug discoveryMoaz M Abdou, Paul M O'Neill, Eric Amigues, et al.BMC Chemistry|November 25, 2023
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screeningMoaz M Abdou, Ferenc Ötvös, Dewen Dong, et al.Protein Science : a Publication of the Protein Society|May 8, 2026
Phosphinate pseudopeptide enhances binding free energy in HIV-1 protease by driving flap closure and suppressing global flexibilityYuxin Xie, Danwen Qiu, Magdalini Matziari, et al.ACS Omega|October 10, 2022
Design, Synthesis, and Study of a Novel RXPA380-Proline Hybrid (RXPA380-P) as an Antihypertensive AgentMoaz M Abdou, Dewen Dong, Paul M O'Neill, et al.Journal of Medicinal Chemistry|March 8, 2008
Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2Andreas Mores, Magdalini Matziari, Fabrice Beau, et al.Plos One|April 4, 2018
Functional examination of novel kisspeptin phosphinic peptidesXiaoyang Zhang, Magdalini Matziari, Yixin Xie, et al.ACS Omega|January 1, 2026
Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking StudiesKomal Hayat, Danwen Qiu, Yuanyuan Wang, et al.International Journal of Cancer|October 23, 2004
Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinasesVincent Dive, Kumari L Andarawewa, Anne Boulay, et al.The Journal of Pharmacology and Experimental Therapeutics|April 26, 2012
Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septumIvan Lazcano, Rosa Maria Uribe, Erick Martínez-Chávez, et al.Peptides|August 16, 2008
Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin releaseRaymundo Cruz, Miguel Angel Vargas, Rosa Maria Uribe, et al.Pageof 3